Proprietary AI analyst is now available
- Public Comps
- Panion & Bf Biotech
Panion & Bf Biotech Valuation Multiples
Discover revenue and EBITDA valuation multiples for Panion & Bf Biotech and similar public comparables like Precision BioSciences, Innate Pharma, ADC Therapeutics, Hyloris Pharmaceuticals and more.
Panion & Bf Biotech Overview
About Panion & Bf Biotech
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. The company along with its subsidiaries is mainly engaged in the manufacture and sales of pharmaceutical, cosmeceutical, diagnostic, medical device, and active pharmaceutical ingredients. It has four core business groups such as disease treatment, disease prevention, disease diagnosis, and delayed aging. It has geographic segments in Taiwan, China, Hong Kong, and Macau, the USA, and Korea. It generates a majority of its revenue from the Taiwan segment.
Founded
1976
HQ

Employees
398
Website
Financials (FY)
EV
$172M
Valuation Multiples
Start free trialPanion & Bf Biotech Financials
Panion & Bf Biotech reported last fiscal year revenue of $65M and EBITDA of $14M.
In the same fiscal year, Panion & Bf Biotech generated $35M in gross profit, $14M in EBITDA, and $6M in net income.
Revenue (LTM)
Panion & Bf Biotech P&L
In the most recent fiscal year, Panion & Bf Biotech reported revenue of $65M and EBITDA of $14M.
Panion & Bf Biotech is profitable as of last fiscal year, with gross margin of 54%, EBITDA margin of 22%, and net margin of 9%.
Financial data powered by Morningstar, Inc.
Panion & Bf Biotech Stock Performance
Panion & Bf Biotech has current market cap of $167M, and enterprise value of $172M.
Market Cap Evolution
Panion & Bf Biotech's stock price is $1.94.
Panion & Bf Biotech share price increased by 1.2% in the last 30 days, and decreased by 14.3% in the last year.
Panion & Bf Biotech has an EPS (earnings per share) of $0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $172M | $167M | 1.2% | 1.2% | -1.4% | -14.3% | $0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPanion & Bf Biotech Valuation Multiples
Panion & Bf Biotech trades at 2.6x EV/Revenue multiple, and 12.2x EV/EBITDA.
EV / Revenue (LTM)
Panion & Bf Biotech Financial Valuation Multiples
As of June 5, 2026, Panion & Bf Biotech has market cap of $167M and EV of $172M.
Panion & Bf Biotech has a P/E ratio of 27.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Panion & Bf Biotech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Panion & Bf Biotech Margins & Growth Rates
In the most recent fiscal year, Panion & Bf Biotech reported gross margin of 54%, EBITDA margin of 22%, and net margin of 9%.
Panion & Bf Biotech Margins
Panion & Bf Biotech Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Panion & Bf Biotech Operational KPIs
Panion & Bf Biotech's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Panion & Bf Biotech Competitors
Panion & Bf Biotech competitors include Precision BioSciences, Innate Pharma, ADC Therapeutics, Hyloris Pharmaceuticals, Acumen Pharmaceuticals, Tenaya Therapeutics, Karolinska Development, NRX Pharmaceuticals, Cereno Scientific and Protalix.
Most Panion & Bf Biotech public comparables operate across Biopharmaceuticals, BioTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.1x | 2.5x | (1.7x) | (1.3x) | |||
| 14.8x | 7.2x | (4.7x) | 4.9x | |||
| 0.7x | 0.7x | (0.6x) | - | |||
| 12.8x | 7.7x | (22.0x) | (11.2x) | |||
| - | - | (0.6x) | (0.6x) | |||
| - | 22.3x | (1.2x) | (1.1x) | |||
| - | - | - | - | |||
| 134.1x | 17.2x | (10.1x) | (10.5x) | |||
This data is available for Pro users. Sign up to see all Panion & Bf Biotech competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Panion & Bf Biotech
| When was Panion & Bf Biotech founded? | Panion & Bf Biotech was founded in 1976. |
| Where is Panion & Bf Biotech headquartered? | Panion & Bf Biotech is headquartered in Taiwan. |
| How many employees does Panion & Bf Biotech have? | As of today, Panion & Bf Biotech has over 398 employees. |
| Is Panion & Bf Biotech publicly listed? | Yes, Panion & Bf Biotech is a public company listed on Taiwan Stock Exchange. |
| What is the stock symbol of Panion & Bf Biotech? | Panion & Bf Biotech trades under 1760 ticker. |
| When did Panion & Bf Biotech go public? | Panion & Bf Biotech went public in 2004. |
| Who are competitors of Panion & Bf Biotech? | Panion & Bf Biotech main competitors include Precision BioSciences, Innate Pharma, ADC Therapeutics, Hyloris Pharmaceuticals, Acumen Pharmaceuticals, Tenaya Therapeutics, Karolinska Development, NRX Pharmaceuticals, Cereno Scientific, Protalix. |
| What is the current market cap of Panion & Bf Biotech? | Panion & Bf Biotech's current market cap is $167M. |
| What is the current revenue of Panion & Bf Biotech? | Panion & Bf Biotech's last fiscal year revenue is $65M. |
| What is the current EV/Revenue multiple of Panion & Bf Biotech? | Current revenue multiple of Panion & Bf Biotech is 2.6x. |
| Is Panion & Bf Biotech profitable? | No, Panion & Bf Biotech is not profitable. |
| How many companies Panion & Bf Biotech has acquired to date? | Panion & Bf Biotech hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Panion & Bf Biotech has invested to date? | Panion & Bf Biotech hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Panion & Bf Biotech
Lists including Panion & Bf Biotech
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.